Taken together, gene expression of both EGFR and INPPL1 is increased in AD brains and SHIP2 protein undergoes alteration in its apparent protein solubility during the progression of AD: SHIP2 is enriched in the insoluble fraction in AD brains together with its known interactor EGFR. This evidence concerns the gene INPPL1 and Alzheimer disease.